Xtalks hosts, Pursuing Parkinson’s Disease Gene Therapies: Strategies & Operational Requirements, a webinar featuring speakers from Premier Research, on April 14.
During the 60-minute webinar, Andreas Schreiner, MD, Vice President, Medical Affairs Neuroscience and Analgesia; and Hanna Wide, MS, Executive Director, Cell and Gene Therapy, will discuss alternate gene therapies such as opto- and chemogenetics and novel genome-editing technology as well as the use of engineered, non-replicating viral vectors, predominantly recombinant adeno-associated virus or lentivirus.
Attendees will learn how to meet the requirements for surgical techniques and equipment when performing intra-CNS administration of viral vectors and operational considerations for Parkinson’s disease gene therapy studies, according to a media release from Xtalks.
The free webinar will take place Wednesday, April 14, 2021 at 11am EDT (4pm BST/UK). For more information and to register, visit Xtalks.
[Source(s): Xtalks, PRWeb]
